Massachusetts
featured
The storm that blanketed the Midwest earlier this week, dumping more than a foot of snow in Kansas and forcing hundreds of flights to be canceled, is now headed for New England. For Boston, it's the third straight weekend of major snow.
» Read More
More
-
NEW YORK, April 5- The stock market's robust rally was slowing even before Friday's jobs report, but the red flag sent up by the weak payrolls data makes the path to more gains less secure.
-
April 5- U.S. securities arbitrators ordered a former employee of Merrill Lynch, Deutsche Bank and Oppenheimer& Co to pay nearly $11 million to an investor who alleged the broker misrepresented securities and made excessive trades.
-
*Dollar on track to rise toward 100- yen mark. NEW YORK, April 5- The U.S. dollar weakened against most major currencies on Friday, dropping to a two-week low against the euro, as worse-than-expected jobs data raised concerns that the pace of recovery in the American labor market has slowed.
-
*About 80 percent of stocks on NYSE, Nasdaq in red. *F5 Networks plunges after weak outlook, weighs on peers. NEW YORK, April 5- The S&P 500 was on track for its worst weekly performance of the year on Friday after weaker-than-expected U.S. jobs data added to worries the U.S. economy could be losing momentum.
-
CAMBRIDGE, Mass.-- InVivo Therapeutics Holdings Corp. said Friday that the Food and Drug Administration will allow it to start human trials of an experimental product that is intended to treat spinal cord injuries. The Cambridge, Mass., company said there are no FDA- approved treatments that intervene directly in the spinal cord following an injury.
-
Speaking bluntly, Ackman, who sits on the JC Penney board and whose $12 billion Pershing Square Capital Management is the company's largest shareholder, said big mistakes have been made remaking the 110 year-old retail brand.
-
April 5- Yankee Candle Co Inc has attracted offers from several private equity firms in a sale process that could value the largest scented candle maker in the United States at about $2 billion, people familiar with the matter said. Madison Dearborn Partners LLC, another buyout firm, acquired Yankee Candle in 2006 for $1.6 billion.
-
But Fidelity Investments and Charles Schwab Corp are paying these financial advisers as much as 0.25 percent of the assets that their clients put in no-transaction-fee mutual funds.
-
The announcements that Secretary of State John Kerry, the richest Cabinet member, Secretary of Homeland Security Janet Napolitano and Treasury Secretary Jacob Lew will voluntarily reduce their pay came a day after President Barack Obama and Defense Secretary Chuck Hagel said they'd return 5 percent of their paychecks to the Treasury.
-
ANNAPOLIS, Md.-- Maryland's already-strong gun laws will become among the strictest in the nation with a measure passed by the General Assembly Thursday, sending the bill to the Democratic governor who proposed the legislation in the aftermath of December's massacre at a Newtown, Conn., elementary school.
-
MILWAUKEE-- The parents of an American journalist kidnapped in Syria more than four months ago said Thursday that his latest disappearance is more upsetting than an earlier one in Libya because they don't know who is holding him.
-
NEW YORK-- New York City's mayor met Thursday with the parents of a Chicago girl killed just days after performing at President Barack Obama's inaugural festivities, then suggested that places interested in reducing gun violence might want to emulate the Big Apple, where studies have found teenagers are less likely to carry weapons than in any other major U.S. city.
-
*Dollar on track to rise toward 100- yen mark. NEW YORK, April 5- The U.S. dollar weakened against most major currencies on Friday, hitting nearly two-week lows against the euro, as weaker-than-expected jobs data raised concerns that the pace of recovery in the American labor market has slowed.
-
Speaking bluntly, Ackman, who sits on the JC Penney board and whose $12 billion Pershing Square Capital Management is the company's largest shareholder, said big mistakes have been made remaking the 110 year-old retail brand.
-
NEW YORK-- Vertex Pharmaceuticals Inc. said Friday it will work with Bristol-Myers Squibb Co. to study a potential hepatitis C treatment regimen that includes Bristol-Myers Squibb's drug daclatasvir and Vertex's VX-135. Hepatitis C is a virus that can lead to life-threatening liver damage and is the main cause of liver transplants in the United States.
-
CAMBRIDGE, Mass.-- Ariad Pharmaceuticals Inc. said Thursday that more than 325 patients have been treated with its drug Iclusig in the three months the leukemia pill has been on the market. Ariad believes European Union regulators will approve Iclusig during the second quarter, and by July 1 it will be prepared to launch the drug in Europe.
-
BOSTON-- Massachusetts reports March collections were up more than 4.8 percent compared with last year. Revenue Commissioner Amy Pitter said Wednesday preliminary revenue collections came in $87 million higher than last March. That's $587 million, or 4 percent, more than a year ago and $363 million above the estimate for this point.
-
CHICAGO, April 3- BBQ fans, brace yourselves: "Pork butt" will soon be a thing of the past. The revised nomenclature emerged after two years of consumer research, which found that the labels on packages of fresh cuts of pork and beef are confusing to shoppers, said Patrick Fleming, director of retail marketing for trade group National Pork Board.
-
*Under new CEO, Sarepta focused on Duchenne muscular dystrophy drug. *Analysts expect company to relay FDA feedback in April. April 2- After three decades without bringing a drug to market, Sarepta Therapeutics Inc stands on the verge of a breakthrough with its treatment for a crippling genetic disorder that affects one in every 3,500 newborn boys.
-
*Healthcare stocks rally, Humana is S&P's top gainer. Humana, which derives about two-thirds of its revenue from Medicare Advantage business, rose 7 percent to $80.11. UnitedHealth Group rose 6.2 percent to $62.67, and Cigna Corp was up 4.1 percent to $65.49.